Fuller & Thaler Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
SCM
Fuller & Thaler Asset Management's HALO Position: Q2 2026 in Review
Fuller & Thaler Asset Management increased its Halozyme (HALO) stake by 1.8% in Q2 2026, buying an estimated $1.75M and bringing the position to 1,491,004 shares worth $117M. The position accounts for 0.32% of the portfolio, ranked #107.
Fuller & Thaler Asset Management first reported a position in HALO in Q1 2020 and has held it in 21 quarters since. 526 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Fuller & Thaler Asset Management held 1,491,004 shares of Halozyme worth $117M as of Q2 2026.
- Fuller & Thaler Asset Management bought 25,721 Halozyme shares in Q2 2026, an estimated $1.75M.
- Halozyme made up 0.32% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #107 holding.
- Fuller & Thaler Asset Management first reported a position in Halozyme in Q1 2020 and has held it in 21 quarters since.
- 526 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.